¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"idiopathic systemic fibrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • bullous systemic lupus erythematosus
    ¹°ÁýÀü½ÅÈ«¹Ý·çǪ½º
  • diffuse systemic sclerosis
    ±¤¹üÀ§Àü½Å°æÈ­Áõ
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯(¼º)³úº´(Áõ)
  • progressive systemic sclerosis
    ÁøÇàÀü½Å°æÈ­Áõ
  • systemic
    1. Àü½Å¼º- 2. ü°èÀû
  • systemic amyloidosis
    Àü½Å¾Æ¹Ð·ÎÀ̵åÁõ
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • systemic death
    Àü½Å»ç¸Á
  • systemic disease
    Àü½Åº´
  • systemic embolism
    Àü½Å»öÀüÁõ
  • systemic hypotension
    Àü½ÅÀúÇ÷¾Ð
  • systemic infection
    Àü½Å°¨¿°
  • systemic inflammatory response syndrome
    Àü½Å¿°Áõ¹ÝÀÀÁõÈıº
  • systemic lesion
    °èÅ뺴ÅÍ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • systemic treatment
    Àü½ÅÄ¡·á
  • systemic therapy
    Àü½Å¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • systemic circulation
    ¿Â¸ö¼øÈ¯, ü¼øÈ¯
  • diffuse systemic sclerosis
    ±¤¹üÀ§Àü½Å°æÈ­Áõ
  • systemic death
    Àü½Å»ç
  • systemic disease
    Àü½Åº´
  • portal-systemic encephalopathy
    ¹®¸ÆÀü½Å¼øÈ¯³úº´Áõ
  • systemic embolism
    Àü½Å»öÀüÁõ
  • infantile systemic hyalinosis
    À¯¾ÆÀü½ÅÀ¯¸®ÁúÁõ
  • systemic hypotension
    Àü½ÅÀúÇ÷¾Ð
  • systemic infection
    Àü½Å°¨¿°
  • systemic lesion
    °èÅ뺴ÅÍ
  • systemic l. erythematosus lupus
    Àü½ÅÈ«¹Ý·çǪ½º
  • systemic mastocytosis
    Àü½Åºñ¸¸¼¼Æ÷Áõ
  • progressive systemic sclerosis
    (¢¡systemic scleroderma) Àü½ÅÇǺΰæÈ­Áõ
  • systemic nodular panniculitis
    Àü½Å°áÀýÁö¹æÃþ¿°
  • systemic reaction
    Àü½Å¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å°æÈ­Áõ
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å¼º °æÈ­Áõ(òäú¼àõ îñãóàõ Ìãûùñø)
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å¼º °æÈ­Áõ(òäú¼àõîñãóàõÌãûùñø).
  • reactive systemic amyloidosis
    ¹ÝÀÀ¼º Àü½Å À¯ÀüºÐÁõ
  • Cystic fibrosis
    ³¶¼º¼¶À¯Áõ(Òªàøàéë«ñø)
  • Fibrosis
    ¼¶À¯Áõ(àéë«ñø), ¼¶À¯È­(àéë«ûù)
  • Hamman Rich syndrome =diffuse interstitial pulmonary fibrosis
    ÇØ¸Õ- ¸®Ä¡ÁõÈıº.
  • arteriocapillary fibrosis
    µ¿¸Æ¸ð¼¼Ç÷°ü¼¶À¯Áõ(¡­Ù¾á¬úìηàéë«ñø).
  • hepatic fibrosis
    °£¼¶À¯Áõ(ÊÜàéë«ñø)
  • postfibrinous fibrosis
    Èļ¶À¯¼Ò¼º ¼¶À¯Áõ(ý­àéë«áÈàõ àéë«ñø)
  • preretinal fibrosis
    ¸Á¸·¾Õ¼¶À¯Áõ
  • preretinal macular fibrosis
    ¸Á¸·¾ÕȲ¹Ý¼¶À¯Áõ
  • progressive nodular fibrosis of the skin
    ÁøÇ༺ °áÀý ÇǺΠ¼¶À¯Áõ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø).
  • pulmonary fibrosis
    Æó¼¶À¯Áõ(øËàéë«ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • endomyocardial fibrosis
    ½É³»¸·½É±Ù¼¶À¯Áõ(ãýҮدãýÐÉàéë«ñø)
  • fibrosis
    ¼¶À¯È­
  • fibrosis syndrome
    ¼¶À¯ÁõÁõÈıº
  • fibrosis,endomyocardial
    ½É³»¸· ±ÙÃþ¼º
  • fibrosis,nodular subepidermal
    °áÀý¼º Ç¥ÇÇÇÏ
  • fibrosis,pipe-stem
    ÆÄÀÌÇÁ °ü
  • fibrosis,pulmonary, coal workers
    Æó, 걤ºÎ
  • fibrosis<³ª>
    ¼¶À¯Áõ(àéë«ñø), ¼¶À¯È­
  • hepatic fibrosis
    °£¼¶À¯Áõ(ÊÜàéë«ñø)
  • liver,pipe-stem fibrosis
    ÆÄÀÌÇÁ°ü¾ç ¼¶À¯È­(¡­Î·åÆ àéë«ûù)
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ(¡­àéë«ñø).
  • myocardium,fibrosis
    ½É±Ù(ãýÐÉ), ¼¶À¯È­(àéë«ûù)
  • neoplastic fibrosis
    Á¾¾ç¼º ¼¶À¯Áõ(¡­àéë«ñø)
  • nodular subepidermal fibrosis
    °áÀý¼º Ç¥ÇÇÇÏ ¼¶À¯Áõ(¡­øúù«ù» àéë«ñø)
  • noncirrhotic portal fibrosis
    ºñ°æÈ­¼º ¹®¸Æ¼¶À¯Áõ.
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary fibrosis
    Æó¼¶À¯Áõ
  • radiation fibrosis
    ¹æ»ç¼±¼¶À¯Áõ
  • radiation fibrosis of lung
    ¹æ»ç¼±Æó¼¶À¯Áõ
  • reactive fibrosis
    ¹ÝÀÀ¼º¼¶À¯È­
  • retroperitoneal fibrosis
    º¹¸·Èļ¶À¯Áõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IPF Idiopathic Pulmonary Fibrosis
IAF idiopathic alveolar fibrosis
IRF idiopathic retroperitoneal fibrosis; impulse response function; interferon regulatory factor; intern...
PSS painful shoulder syndrome; physiologic saline solution; porcine stress syndrome; primary Sjogren syn...
SMCD senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFTR Cystic Fibrosis Transmembrane Conductance Regulator Gene
CFTR Cystic Fibrosis Transmembrane Regulator
CFP Cystic fibrosis protein
EMF Endomyocardial fibrosis
IPF Interstitial pulmonary fibrosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • idiopathic histiocytosis
    Ư¹ß¼º Á¶Á÷±¸Áõ, Ư¹ß¼º Á¶Á÷±¸ Áõ½ÄÁõ
    ÀÌÀü¿¡´Â Á¶Á÷±¸ Áõ½ÄÁõ X¶ó°í ºÒ·¶À¸¸ç ±âº»ÀûÀÎ º´º¯Àº ¼¼¸Á ³»ÇÇ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ¸ç ¹ßº´ ¿¬·É ¹× ¿¹ÈÄ¿¡ µû¶ó Letterer-Siwe Áúȯ, Hand-schuller-christian Áúȯ, È£»ê¼º À°¾ÆÁ¾À¸·Î ºÐ·ùÇÑ´Ù.
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º °úÇü¼º °ñ°üÀýº´Áõ
  • idiopathic intraoral burning
    Ư¹ß¼º ±¸°­ ÀÛ¿­°¨
  • idiopathic melanoplakia
    Ư¹ß¼º Èæ¹ÝÁõ
  • idiopathic odontalgia
    Àڹ߼º Ä¡Åë, Ư¹ß¼º Ä¡Åë
    ¿øÀÎ ºÒ¸íÀ̰ųª ¸í¹éÇÑ º´¼Ò°¡ ¾ø´Â Ä¡¾Æ ÅëÁõ.
  • idiopathic orthostatic hypotension
    Ư¹ß¼º ±â¸³¼º ÀúÇ÷¾ÐÁõ
  • idiopathic pain
    Àڹ߼º ÅëÁõ, Ư¹ß¼º µ¿Åë
    ¿øÀÎÀ̳ª º´¼Ò¸¦ ¸ð¸£´Â ÅëÁõ¼º ÁúȯÀ̳ª Àå¾Ö.
  • idiopathic resorption of tooth
    Ư¹ß¼º Ä¡¾Æ Èí¼ö
  • idiopathic sprue
    Ư¹ß¼º ½ºÇÁ·ç¿ì
  • idiopathic thrombocytopenia
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼ÒÁõ
  • idiopathic trigger point mechanism
    Ư¹ß¼º ¹ßÅëÁ¡ ±âÀü
  • subacute asymmetric idiopathic polyneuritis
    ¾Æ±Þ¼º ºñ´ëμº Ư¹ß¼º ´Ù¹ß ½Å°æ¿°
  • portal-systemic venous collateral circulation
    °£ ¹®¸Æ-Àü½Å Á¤¸ÆÀÇ ÃøÁö ¼øÈ¯
  • progressive systemic sclerosis
    ÁøÇ༺ Àü½Å °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °æÈ­Áõ, ÁøÇ༺ Àü½Å¼º °øÇÇÁõ
  • surgically contructed systemic-pulmonary shunts
    ¿Ü°úÀûÀ¸·Î Çü¼ºÇØÁØ Àü½Å-Æó¼º ´Ü¶ô
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cystic fibrosis antigen Now known to be MRP 8.
See: calgranulins.
(18 Nov 1997)
cystic fibrosis transmembrane conductance regulator Gene believed to be defective in cystic fibrosis. Gene encodes a chloride channel, homologous to a family of proteins that actively transport small solutes in an ATP dependent manner (ABC transporters).
The regulator protein is a protein which is embedded in the cell membrane and acts as a channel for certain ions to be transported into or out of the cell. The disease cystic fibrosis is caused by a defect in the gene for this protein.
(09 Oct 1997)
progressive massive fibrosis <radiology> Progressive massive fibrosis, silicosis (properly conglomerate nodules, not progressive massive fibrosis), coal worker's pneumoconiosis, density (conglomerate mass) in upper lobe, retracts toward hilum, leaves emphysematous change (bullae) at lung periphery
(12 Dec 1998)
scleroderma, systemic A chronic, progressive dermatosis characterised by boardlike hardening and immobility of the affected skin, with visceral involvement, especially of lungs, oesophagus, kidneys and heart. It may be accompanied by calcinosis, raynaud's phenomenon, and telangiectasis (crest syndrome). It includes acrosclerosis and sclerodactyly.
(12 Dec 1998)
pulmonary fibrosis Chronic inflammation and progressive fibrosis of the pulmonary alveolar walls, with steadily progressive dyspnea, resulting finally in death from oxygen lack or right heart failure.
(12 Dec 1998)
subadventitial fibrosis Fibrosis in the outer media of arteries, usually the renal arteries of young women, where it causes segmental stenosis and hypertension; a variety of fibromuscular dysplasia.
Synonym: subadventitial fibrosis.
(05 Mar 2000)
nodular subepidermal fibrosis A slowly growing benign skin nodule consisting of poorly demarcated cellular fibrous tissue enclosing collapsed capillaries with scattered haemosiderin-pigmented and lipid macrophages. They are common, usually about 1 cm in diameter and occur in the dermis. Simple excision is always curative.
(12 Dec 1998)
Symmers' fibrosis A characteristic pipe-shaped fibrosis formed around hepatic portal veins in some cases of long-continued heavy infection with Schistosoma mansoni; thought to be induced by the presence of large numbers of schistosome eggs in the hepatic tissues.
Synonym: Symmers' clay pipestem fibrosis, Symmers' fibrosis.
(05 Mar 2000)
systemic <anatomy> Pertaining to or affecting the body as a whole.
(18 Nov 1997)
systemic anaphylaxis The immediate response, involving smooth muscles and capillaries throughout the body of a sensitised individual, that follows intravenous (and occasionally intracutaneous) injection of antigen (allergen).
See: anaphylactic shock.
Synonym: systemic anaphylaxis.
(05 Mar 2000)
systemic anatomy Anatomy of the systems of the body; an approach to anatomical study organised by organ systems, e.g., the cardiovascular system, emphasizing an overview of the system throughout the body; distinguished from regional anatomy.
(05 Mar 2000)
systemic autoimmune diseases A group of connective tissue disease's characterised by the presence of autoantibodies responsible for immunopathologically mediated tissue lesions; systemic lupus erythematosus is the prototype.
(05 Mar 2000)
systemic blastomycosis Infection with Blastomyces dermatitidis extending beyond the skin or the lung, the usual portals of entry; involvement of bone and genitourinary tract (especially. Prostate and epididymis) are most frequent.
(05 Mar 2000)
systemic chondromalacia A degenerative disease of cartilage producing a bizarre form of arthritis, with collapse of the ears, the cartilaginous portion of the nose, and the tracheobronchial tree; death may occur from chronic infection or suffocation because of loss of stability in the tracheobronchial tree of autosomal origin.
Synonym: chronic atrophic polychondritis, generalised chondromalacia, Meyenburg's disease, Meyenburg-Altherr-Uehlinger syndrome, relapsing perichondritis, systemic chondromalacia, von Meyenburg's disease.
(05 Mar 2000)
systemic circulation The circulation of blood through the arteries, capillaries, and veins of the general system, from the left ventricle to the right atrium.
Synonym: greater circulation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á